IDH2 mutant-TF-1 Isogenic-Luc2
CRL-2003IG-LUC2 ™
IDH2 mutant-TF-1 Isogenic-Luc2 is an erythroblast cell line that was isolated in 2018 from the marrow of an Asian, 35-year-old, male patient with erythroleukemia. This cell line was deposited by ATCC and can be used in assay development, drug development, drug resistance research, immune system disorder research, and immunology research.
For‑profit customers intending to use this product for non-commercial screening must include the one-time “ATCC Screening Fee” (ATCC ACS‑2103F) with their first purchase of this product.